Euro plan for chemicals giant
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SENIOR EXECUTIVES at Aventis, the new $20bn Euro company born out of the merger of the life sciences operations of chemicals giants Hoechst and Rhone Poulenc, said yesterday that they are lobbying to be allowed to create a European company which will avoid them having to upset one or other party to the merger by registering in Germany or France. The idea of a European company has been tabled repeatedly by Brussels but has always collapsed because of an inability to reconcile the British practice of shareholder-owned companies with the Germanic principle of worker representation on company boards.
Jurgen Dormann, the Hoechst chief executive who will run the new company from an as-yet unbuilt headquarters in Strasbourg, wants to see the new Euro company law on the statute books before Hoechst and Rhone-Poulenc move to a full merger in 2001.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments